Clinical Trial Applications - Approved: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | Date Approved | |
|---|---|---|---|---|---|
1. |
ECCT/26/06/03 | C1091009 - Study Site 1254 Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants |
Principal Investigator(s) 1. Fredrick Kipyego Sawe Site(s) in Kenya 1. Kenya Medical Research Institute Walter Reed Project (Kericho county) 2. KEMRI Butere Clinical Research Centre (Kakamega county) 3. Kenya Medical Research Institute (KEMRI) - Centre for Global Health Research (Kisumu county) 4. Victoria Biomedical Research Institute Kisumu County Referral Hospital (Kisumu county) |
08-11-2026 |
View |
2. |
ECCT/26/06/02 | HibiscusJr A global phase 3 Randomised, Double-blind and Placebo-controlled Study Evaluating the Efficacy and Safety of etavopivat in children with Sickle Cell Disease. |
Principal Investigator(s) 1. Dr. Sharon Mokeira Ocharo Site(s) in Kenya 1. Victoria Biomedical Research Institute (Kisumu county) |
23-10-2026 |
View |
3. |
ECCT/26/06/01 | SANDLY A Phase 1, Multi-Site, Double-Blinded, Placebo-Controlled Dose-Escalation Study to Evaluate the Safety and Immunogenicity of Leishmania major LmCen -/- vaccine in healthy Kenyan and Brazilian Adults (SANDFLY) |
Principal Investigator(s) 1. JOSPHAT KOSGEI Site(s) in Kenya KEMRI WRP CRC KERICHO |
08-11-2026 |
View |
4. |
ECCT/26/05/01 | C1091009 Study site 1193 Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants |
Principal Investigator(s) 1. Janet Nyawira Oyieko Site(s) in Kenya 1. KEMRI Butere Clinical Research Centre (Kakamega county) 2. Kenya Medical Research Institute Walter Reed Project (Kericho county) 3. Kenya Medical Research Institute (KEMRI) - Centre for Global Health Research (Kisumu county) 4. Victoria Biomedical Research Institute Kisumu County Referral Hospital (Kisumu county) |
08-11-2026 |
View |
5. |
ECCT/26/04/02 | IGHID 12430/DELIVER-02 IGHID12430/DELIVER-02 - A PHASE 1, OPEN LABEL,STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF MGD014 AND MGD020 WITH A LATENCY REVERSAL AGENT VERSUS TEMPORARY TREATMENT INTERRUPTION IN PERSONS WITH HIV-1 ON ANTIRETROVIRAL THERAPY |
Principal Investigator(s) 1. Charity Wambui Kanyoro Site(s) in Kenya 1. Moi University Clinical Research Centre(MUCRC), Eldoret, Kenya (Uasin Gishu county) 2. Kericho Clinical Research Center (Kericho CRC), Kericho, (Kericho county) |
25-06-2026 |
View |
6. |
ECCT/26/04/01 | ACRN-MNK02-301 A Phase 3, randomized, double-blind, placebo-controlled trial to evaluate the effect of Bifidobacterium longum subsp. infantis DSM33361(Bifin02) administered together with Lacticaseibacillus rhamnosus GG DSM33156 (LGG ®) versus placebo on weight gain in underweight infants. |
Principal Investigator(s) 1. Prof. Videlis Nduba Site(s) in Kenya 1. KEMRI-CRDR (Nairobi City county) 2. KEMRI-MTWAPA (Kilifi county) 3. Moi University Clinical Research Centre (Uasin Gishu county) |
21-10-2026 |
View |
7. |
ECCT/26/03/03 | LIBRA A 52-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group, group sequential, Phase 3 study to evaluate the efficacy and safety of rilzabrutinib in patients aged 10 to 65 years with sickle-cell disease (LIBRA) |
Principal Investigator(s) 1. Jessie Githanga Site(s) in Kenya Getrudes’s Children\'s Hospital |
23-10-2026 |
View |
8. |
ECCT/26/03/02 | E-MASTER STUDY: PHASE 1 Diagnosis of postpartum haemorrhage at caesarean section: a multi-country diagnostic and prognostic accuracy study (E-MASTER: PHASE 1) |
Principal Investigator(s) 1. Zahida Qureshi 2. Alfred Osoti 3. George Gwako Site(s) in Kenya 1. St Marys Mission Hospital-Langata (Nairobi City county) 2. Mbagathi County Referral Hospital (Nairobi City county) |
04-06-2026 |
View |
9. |
ECCT/26/03/01 | C1091009 Study A Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants |
Principal Investigator(s) 1. Lucas Otieno Tina Site(s) in Kenya 1. Victoria Biomedical Research Institute Kisumu County Referral Hospital (Kisumu county) 2. KEMRI Butere Clinical Research Centre (Kakamega county) 3. Kenya Medical Research Institute Walter Reed Project (Kericho county) 4. Kenya Medical Research Institute (KEMRI) - Centre for Global Health Research (Kisumu county) |
26-08-2026 |
View |
10. |
ECCT/26/02/08 | SOAR Study Optimizing Smoking Cessation and Unhealthy Alcohol Use Treatment Among People Living with Human Immunodeficiency Virus (PLWH) In Nairobi, Kenya Abbreviated as SOAR Study Smoking cessation Optimization and unhealthy Alcohol use Research, SOAR, Study. |
Principal Investigator(s) 1. DR. EMILY KOECH Site(s) in Kenya Riruta Hospital |
19-06-2026 |
View |